Skip to main content
Clinical Trials/NCT04221685
NCT04221685
Unknown
Not Applicable

Intraoperative Pain During Extraction of Maxillary Primary Molars Using Artpharma Versus Artinibsa in Children After Infiltration Technique: a Randomized Clinical Trial

Cairo University0 sites130 target enrollmentDecember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
Cairo University
Enrollment
130
Primary Endpoint
Intraoperative pain.
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to assess Intraoperative pain for extraction of Maxillary primary molars using Artpharma Versus Artinibsa in children during infiltration technique.

Detailed Description

Articaine is used for pain control Like other local anesthetic drugs, articaine causes a temporary and completely reversible state of anesthesia (loss of sensation) during (dental) procedures.This local anesthesia was first synthesized by Rusching in 1969, and carried to the market in Germany by Hoechst AG, a life-sciences German company, under the brand name Ultracain ,it entered clinical practice in Germany in 1976. The name was changed in 1984, the year it was released in Canada. It then entered the United Kingdom in 1998, the United States in 2000 and Australia in 2005. At this time, articaine is available as a 4% solution containing 1:100, 000 or 1:200, 000 adrenaline. Articaine has been widely used in dental surgery.It started to use carticaine around 1977.In dentistry has been investigated widely. Articaine is a unique amide LA in that it contains a thiophene, instead of a benzene ring.The thiophene ring allows greater lipid solubility and effectiveness as a greater portion of an administered dose can enter neurons

Registry
clinicaltrials.gov
Start Date
December 1, 2020
End Date
December 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hafedha Hashem Abdullah

Principle Investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Children aged 6-9 years.
  • Children with maxillary primary molars indicated for extraction.

Exclusion Criteria

  • Children with medical conditions.
  • Uncooperative children.
  • Parents or guardians who refuse participating in the study.

Outcomes

Primary Outcomes

Intraoperative pain.

Time Frame: immediate

Intraoperative pain: is measuring by using Wong Baker visual analogue scale and measuring unite is Scale (0-10).

Secondary Outcomes

  • Onset of anesthesia.(Immediate)
  • Pain during injection(success rate).(immediate)
  • The sensation after injection.(Immediate)

Similar Trials